Research into Pancreatic Cancer is more crucial than ever, and we are proud to support a project aimed at addressing this challenge.
Over the past 50 years, survival rates for many types of cancer have significantly improved. Unfortunately, this is not the case for pancreatic cancer, where only marginal progress has been made.
With the backing of Clatterbridge Cancer Charity, Consultant Prof. Dan Palmer and his collaborator Prof. Ainhoa Mielgo from the University of Liverpool are conducting a scientific trial involving 40 Clatterbridge patients. Their goal is to better understand how initial treatments for pancreatic cancer may be effective against the primary tumor but could also inadvertently aid the spread of cancer to other organs, particularly the liver.
By gaining deeper insights into the biology of this process, Dan and Ainhoa aim to refine current treatments and slow the progression of this often deadly disease. This research holds the potential to make a significant impact on the lives of pancreatic cancer patients, offering hope for improved outcomes.
Your support is essential in making this vital research possible. Together, we can contribute to the fight against pancreatic cancer and help pave the way for better treatments and survival rates.
Sign up for our newsletter
We’d love to keep you updated about how you make a difference to the lives of patients and their families at The Clatterbridge Cancer Centre and more ways you can support the 1 in 2 people with cancer across our region.
Your details are safe with us. More information about how we protect your personal data is set out in our privacy policy.
